Understanding What Causes Long COVID
Tirzepatide is a dual-agonist targeting GLP-1 and GIP receptors, while retatrutide is a triple-agonist that also activates the glucagon receptor
You can use these as much as is comfortable dont bang away at the pain site, this is not a no pain no gain type of situation
In contrast, a 54-week trial of liraglutide did not show significant motor improvement (MDS-UPDRS III), but daily living activities (MDS-UPDRS II) improved significantly, suggesting functional gains without direct motor benefit [57]
Coordinate with prescribers to ensure supply aligns with the titration plan, especially during the early months of treatment
Stopping abruptly often leads to weight regain, so work with your provider on a gradual plan if discontinuation is the goal